Literature DB >> 25863827

Subthreshold and threshold DSM-IV generalized anxiety disorder in Singapore: Results from a nationally representative sample.

Siau Pheng Lee1, Vathsala Sagayadevan2, Janhavi Ajit Vaingankar2, Siow Ann Chong2, Mythily Subramaniam2.   

Abstract

Previous nationally representative studies have reported prevalence of DSM-IV generalized anxiety disorder (GAD). However, subthreshold and threshold GAD expressions remain poorly understood. The current study examined the prevalence, correlates and co-morbidity of a broader diagnosis of GAD in Singapore. The Singapore Mental Health Study (SMHS) was an epidemiological survey conducted in the population (N=6616) aged 18 years and older. The Composite International Diagnostic Interview version 3.0 (CIDI 3.0) was used to establish mental disorder diagnoses. The lifetime prevalence for subthreshold GAD (2.1%) and threshold GAD (1.5%) in the current sample was found to be lower than in Western populations. Younger age group, Indian ethnicity, previously married, chronic physical conditions, and being unemployed were associated with higher odds of having more severe expression of generalized anxiety. The relatively lower prevalence rate of subthreshold GAD expression suggests possible cultural interferences in the reporting and manifestation of anxiety symptomatology. Despite the low prevalence, significant impacts on functioning and comorbidity among subthreshold generalized anxiety cases indicate the importance of early treatment to ensure a better prognosis.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Comorbidity; Disability; Epidemiology; Population-based survey; Prevalence; Singapore

Mesh:

Year:  2015        PMID: 25863827     DOI: 10.1016/j.janxdis.2015.03.008

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  1 in total

1.  Mental Disorder, Psychological Distress, and Functional Status in Canadian Military Personnel.

Authors:  Hugues Sampasa-Kanyinga; Mark A Zamorski; Ian Colman
Journal:  Can J Psychiatry       Date:  2018-02-28       Impact factor: 4.356

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.